Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines

By Epplen Robin   Stöckle Michael   Engelmann Udo   Heidenreich Axel   Ohlmann Carsten-Henning  

Acta Oncologica, Vol. 50, Iss. 1, 2011-01 ,pp. : 127-133

Informa Healthcare

Access to resources Recommend Favorite

Integrins and Prostate Cancer Metastases

By Fornaro M.   Manes T.   Languino L.R.  

Cancer and Metastasis Reviews, Vol. 20, Iss. 3-4, 2001-12 ,pp. : 321-331

Springer Publishing Company

Access to resources Recommend Favorite

Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study

By Ripamonti Carla  

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1177-1184

Springer Publishing Company

Access to resources Recommend Favorite

The role of enzalutamide in the treatment of castration-resistant prostate cancer

By Rawlinson Alex   Mohammed Aza   Miller Marek   Kunkler Roger  

Future Oncology, Vol. 8, Iss. 9, 2012-09 ,pp. : 1073-1081

Future Medicine

Access to resources Recommend Favorite

Contemporary Role of Endocrine Treatment in Patients with Localized or Locally Advanced Prostate Cancer: A Review

By  

Current Cancer Therapy Reviews, Vol. 7, Iss. 3, 2011-08 ,pp. : 201-214

Bentham Science Publishers

Access to resources Recommend Favorite